In addition, we reported miR-21 to induce stemness of colon cancer cells by down-regulating TGFβR2 and that down-regulation of miR-21 induces differentiation of CR colon cancer cells and enhances susceptibility to therapeutic regimens [8,17]. This evidence concerns the gene TGFBR2 and malignant colon neoplasm.